Elevating theranostics: The emergence and promise of radiopharmaceutical cell‐targeting heterodimers in human cancers is a research paper published in iRadiology (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: R01CA269221
Foundation for the National Institutes of Health
Grant: R01CA225837
National Institutes of Health
Grant: 5R01CA269221-03
Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment
National Institutes of Health
Grant: 5R01CA225837-04
Novel Receptor-Targeting Peptides for Melanoma Therapy
National Institutes of Health
Grant: 3U01HL152410-02S1
Midwest Biomedical Accelerator Consortium: MBArC
BLRD VA
Grant: I01 BX000964
NHLBI NIH HHS
Grant: U01 HL152410
FWCI
2.94
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals